For example, a meta-analysis involving 7668 COVID-19 patients reported that while elevated VEGF-A levels were generally predictive of poor outcomes, significant heterogeneity across studies suggested that the prognostic utility of VEGF-A may depend on the population and local clinical practices [48]. Here, VEGFA is linked to COVID-19.